Addiction Medicine Journal Club
Health & Fitness:Medicine
7. Treating Opioid and Polysubstance Use Disorders
In Episode 7 we discuss treating opioid use disorder with co-occurring polysubstance use.
Xu KY, Mintz CM, Presnall N, Bierut LJ, Grucza RA. Comparative Effectiveness Associated With Buprenorphine and Naltrexone in Opioid Use Disorder and Cooccurring Polysubstance Use. JAMA Netw Open. 2022;5(5):e2211363. 2022 Aug 3.
We also discuss the Society of Hospital Medicine’s new consensus statement about management of opioid use disorder in the hospital, and hepatotoxicity from depot buprenorphine.
Calcaterra SL, Et. Al. Management of opioid use disorder and associated conditions among hospitalized adults: A Consensus Statement from the Society of Hospital Medicine. J Hosp Med. 2022 Jul 26.
A free summary of the recommendations is in ACP Hospitalist.
----------
This podcast offers category 1 and MATE-ACT CME credits through MI CARES and Michigan State University. To get credit for this episode and others, go to this link to make your account, take a brief quiz, and claim your credit. To learn more about opportunities in addiction medicine, please visit MI CARES.
----------
Episode 7 Credits:
----------
This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice.
The best part of any journal club is the conversation. Send us your comments on Twitter, Facebook, YouTube, email, or join our Facebook group.
Addiction Medicine Journal Club is intended for educational purposes only and should not be considered medical advice. The views expressed here are our own and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.
Create your
podcast in
minutes
It is Free